Follow-up monitoring in a cat with leishmaniosis and coinfections with Hepatozoon felis and ‘Candidatus Mycoplasma haemominutum’

Attipa, Charalampos; Neofytou, Kyriaki; Yiapanis, Christos; Martínez-Orellana, Pamela; Baneth, Gad; Nachum-Biala, Yaarit; Brooks-Brownlie, Harriet; Solano-Gallego, Laia; Tasker, Séverine

Leishmania infantum, the causative agent of canine leishmaniosis in Europe and a zoonotic vector-borne pathogen, has been increasingly reported in cats in the Mediterranean basin, providing mounting evidence that cats may act as a secondary reservoir. 1 Experimental and case-control studies on feline leishmaniosis (FeL) are lacking, limiting our knowledge of this disease; thus epidemiological studies, case series and case descriptions are required to establish a better understanding of the clinicopathological presentations, treatment, monitoring and prevention of FeL. 2 Herein, we describe the clinical, laboratory and molecular findings, as well as treatment and prolonged monitoring data, from an adult domestic shorthair cat from Cyprus diagnosed with leishmaniosis caused by Leishmania infantum and coinfections with Hepatozoon felis and 'Candidatus Mycoplasma haemominutum' (CMhm).